[HTML][HTML] Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies

L Zhou, W Yan, S Li, H Yang, X Zhang, W Lu… - Journal of Global …, 2022 - ncbi.nlm.nih.gov
Background We aimed to quantitatively summarise the health economic evaluation
evidence of prevention and control programs addressing COVID-19 globally. Methods We …

[HTML][HTML] Economic evaluation of COVID-19 vaccination: A systematic review

AM Utami, F Rendrayani, QA Khoiry… - Journal of global …, 2023 - ncbi.nlm.nih.gov
Background Safe and effective vaccination is considered to be the most critical strategy to
fight coronavirus disease 2019 (COVID-19), leading to individual and herd immunity …

Economic evaluation of strategies against coronavirus: a systematic review

R Izadi, N Hatam, F Baberi, S Yousefzadeh… - Health Economics …, 2023 - Springer
Background The COVID-19 outbreak was defined as a pandemic on 11 March 2020 by the
World Health Organization. After that, COVID-19 has enormously influenced health systems …

Prevalence and factors associated with not receiving the booster dose of the COVID-19 vaccine in adults in Latin America and the Caribbean

D Urrunaga-Pastor, D Fernandez-Guzman… - Travel Medicine and …, 2022 - Elsevier
Background Booster doses have been described as effective in reducing hospitalizations
and deaths from the new variants. However, its coverage is heterogeneous in Latin America …

Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study

RK Mohapatra, S Mishra, V Kandi… - Health Science …, 2023 - Wiley Online Library
Abstract Background and Aim Understanding the prevalence and impact of SARS‐CoV‐2
variants has assumed paramount importance. This study statistically analyzed to effectively …

Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States

M Di Fusco, K Marczell, KA Deger… - Journal of Medical …, 2022 - Taylor & Francis
Background As the body of evidence on COVID-19 and post-vaccination outcomes
continues to expand, this analysis sought to evaluate the public health impact of the Pfizer …

Cost‐effectiveness of COVID‐19 vaccination: A systematic review

Y Fu, J Zhao, P Han, J Zhang, Q Wang… - Journal of Evidence …, 2023 - Wiley Online Library
Objective The COVID‐19 vaccination strategy has been widely used to protect population
health worldwide. This study aims to summarize the cost‐effectiveness evidence of …

[HTML][HTML] Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study

Z Zou, CK Fairley, M Shen, N Scott, X Xu, Z Li… - International Journal of …, 2022 - Elsevier
Objectives The exact characteristics of a coronavirus disease 2019 (COVID-19) outbreak
that trigger public health interventions are poorly defined. The aim of this study was to …

Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divide

L Zhang, H Liu, Z Zou, S Su, JJ Ong, F Ji… - The Lancet Regional …, 2023 - thelancet.com
Background We evaluate the impact and cost-effectiveness of shared primary-specialty
chronic hepatitis B (CHB) care models in China. Methods We constructed a decision-tree …

Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients

Y Joo, DK Kim, YG Jeon, AR Kim, HN Do, SY Yoon… - Vaccines, 2023 - mdpi.com
Dialysis patients are more likely to die or become hospitalized from coronavirus disease
2019 (COVID-19). Currently, only a few studies have evaluated the efficacy of a fourth …